Late relapse in patients with diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

Late relapse in patients with diffuse large B-cell lymphoma

Published:2010-09-29 Issue:4 Volume:151 Page:354-358
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Vose Julie M.,Weisenburger Dennis D.,Loberiza Fausto R.,Arevalo Alejandro,Bast Martin,Armitage Joel,Bierman Philip J.,Bociek Robert G.,Armitage James O.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2010.08330.x/fullpdf

Reference22 articles.

1. Combination chemotherapy in non-Hodgkin’s lymphoma: results of long-term followup;Anderson;Cancer Treatment Reports,1977

2. Interpretation of clinical trials in diffuse large-cell lymphoma;Armitage;Journal of Clinical Oncology,1988

3. Clinical, biologic, and histologic features of late relapses in diffuse large cell lymphoma;Cabanillas;Blood,1992

4. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;New England Journal of Medicine,2002

5. Advanced diffuse histiocytic lymphoma, a potentially curable disease;DeVita;Lancet,1975

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreased lymphoma-related deaths and improved long-term relative survival with radiotherapy for early-stage diffuse large B-cell lymphoma in the rituximab era;Radiotherapy and Oncology;2023-11

2. Safety and efficacy of high‐dose cytarabine MEAM therapy and other treatments for auto‐peripheral blood stem cell transplantation: A retrospective comparative study;Asia-Pacific Journal of Clinical Oncology;2022-05-22

3. Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions;Cancers;2021-11-20

4. Exosomes and extracellular vesicles as liquid biopsy biomarkers in diffuse large B‐cell lymphoma: Current state of the art and unmet clinical needs;British Journal of Clinical Pharmacology;2020-11-18

5. Cost utility analysis of tisagenlecleucel vs salvage chemotherapy in the treatment of relapsed/refractory diffuse large B-cell lymphoma from Singapore’s healthcare system perspective;Journal of Medical Economics;2020-08-25